Open AccessPreoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism
Author(s) -
Sabaretnam Mayilvaganan,
Vijaya Sarathi,
C Shivaprasad
Publication year - 2017
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.196023
Subject(s) - medicine , zoledronic acid , primary hyperparathyroidism , bisphosphonate , surgery , parathyroid hormone , hyperparathyroidism , osteoporosis , urology , calcium
Hungry bone syndrome is a common complication of surgery for primary hyperparathyroidism in India which often leads to prolonged hospitalization. There are varying reports on the use and efficacy of bisphosphonates in the prevention of hungry bone syndrome.